You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

levoleucovorin

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Unresectable or Metastatic Esophageal Cancer Trial (Futibatinib, Pembrolizumab, Cisplatin)

Not yet recruiting
  • Locally Advanced Unresectable or Metastatic Esophageal Cancer
  • (no location specified)
Jul 6, 2023

Colorectal Tumors, Tumor Metastasis, Colonic Tumors Trial in Seoul (Atezolizumab, Bevacizumab, Oxaliplatin)

Active, not recruiting
  • Colorectal Neoplasms
  • +3 more
  • Seoul, Songpa-gu, Korea, Republic of
    Asan Medical Center
Jul 6, 2022

Colorectal Tumors Trial in United States (tucatinib, trastuzumab, bevacizumab)

Recruiting
  • Colorectal Neoplasms
  • Anaheim, California
  • +13 more
Aug 15, 2022

Esophageal Squamous Cell Carcinoma (ESCC), Gastroesophageal Junction Carcinoma (GEJC), Esophageal Adenocarcinoma (EAC) Trial in

Recruiting
  • Esophageal Squamous Cell Carcinoma (ESCC)
  • +2 more
  • pembrolizumab
  • +7 more
  • Long Beach, California
  • +158 more
Jan 19, 2023

Metastatic Esophageal Squamous Cell Carcinoma Trial in Worldwide (Pembrolizumab, Lenvatinib, Cisplatin)

Recruiting
  • Metastatic Esophageal Squamous Cell Carcinoma
  • Louisville, Kentucky
  • +91 more
Mar 30, 2022

Metastatic Colorectal Cancer Trial in Fuzhou (Irinotecan, Oxaliplatin, Levoleucovorin)

Withdrawn
  • Metastatic Colorectal Cancer
  • Fuzhou, Fujian, China
    Rongbo Lin
Mar 23, 2018